Company / Depreciation & Amortization
Anika Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$5.4M
FY2025
5-year range
$5.0M / $6.9M
FY2021-FY2025
Trend
-22.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $4M in FY2018 to $7M in FY2024.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -1.9%.
Improved from $6M to $5M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -4.1%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.9%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 22.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4M | -22.0% |
| FY2024 | $6.9M | +7.0% |
| FY2023 | $6.4M | +5.8% |
| FY2022 | $6.1M | +22.7% |
| FY2021 | $5.0M | -16.1% |
| FY2020 | $5.9M | +37.8% |
| FY2019 | $4.3M | +14.9% |
| FY2018 | $3.7M | -1.1% |
| FY2017 | $3.8M | -19.8% |
| FY2016 | $4.7M | -1.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026